Copenhagen, Hovedstaden, Denmark DKA Capital is the famous VC, which was founded in 1984. The main department of described VC is located in the Copenhagen. The company was established in Europe in Denmark.
The increased amount of exits for fund were in 2000. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this DKA Capital works on 31 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2000.
Among the most successful fund investment fields, there are Medical, Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Denmark. Among the most popular portfolio startups of the fund, we may highlight NsGene, HepaVec AG, Hymite.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the DKA Capital, startups are often financed by Themis Equity Partners, TVM Capital, Innovations Kapital. The meaningful sponsors for the fund in investment in the same round are VF Venture, Techno Venture Management, TVM Capital. In the next rounds fund is usually obtained by Thuja Capital, Office of the Chief Scientist of Israel - OCS, AlpInvest Partners.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hymite | $11M | 11 Jan 2007 | Denmark, Capital Region of Denmark, Denmark | ||
Direct Conversion | $25M | 01 Jul 2002 | Danderyd, Stockholms Lan, Sweden | ||
Develogen AG | $47M | 18 Apr 2001 | Lower Saxony | ||
| $4M | 08 May 2000 | Berlin | |||
ACADIA Pharmaceuticals | $3M | 13 Aug 1997 | San Diego, California, United States | ||
ACADIA Pharmaceuticals | $6M | 04 Feb 1997 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hymite | $11M | 11 Jan 2007 | Denmark, Capital Region of Denmark, Denmark | ||
Direct Conversion | $25M | 01 Jul 2002 | Danderyd, Stockholms Lan, Sweden | ||
Develogen AG | $47M | 18 Apr 2001 | Lower Saxony | ||
| $4M | 08 May 2000 | Berlin | |||
ACADIA Pharmaceuticals | $3M | 13 Aug 1997 | San Diego, California, United States | ||
ACADIA Pharmaceuticals | $6M | 04 Feb 1997 | San Diego, California, United States |
